What is Cytarabine?
Category: Prescription Drugs
Most popular types: Ara-C Cylocide Cytosar-U Show all
See also: CALGB 9251 CODOX-M/IVAC Cytarabine-Daunorubicin Cytarabine-Doxorubicin Cytarabine-Idarubicin
Cytarabine (Cytosar-U, Ara-C) is an antimetabolite used in the treatment of acute myeloid leukemia, acute lymphocytic leukemia, blast phase of chronic myelocytic leukemia, and lymphomas; also for prophylaxis and treatment of meningeal leukemia.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Acute myeloid leukemia | 27 | 1 | |
| Acute lymphocytic leukemia | 24 | 0 | |
| Diffuse large B-cell lymphoma | 2 | 1 | |
| Acute promyelocytic leukemia | 1 | 3 | |
| Bone marrow transplant | 1 | 1 | |
| Follicular lymphoma | 1 | 1 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 4 | |
| Mild | 0 | |
| None | 0 |
Commonly reported side effects and conditions associated with Cytarabine
| Side effect | Patients | Percentage |
|---|---|---|
| Nausea | 2 | |
| Fever | 1 | |
| Hearing problems | 1 | |
| Rashes (redness, swelling) | 1 | |
| Spinning dizziness (vertigo) | 1 |
Why patients stopped taking Cytarabine
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Course of treatment ended | 3 | |
| Did not seem to work | 1 |
Duration
Stopped taking Cytarabine
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 3 | |
| 1 - 6 months | 1 |
What people switch to and from
Patients stopped taking Cytarabine and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Decitabine (Dacogen) | 1 |
Last updated: